Cancer vaccines show promise for treatment and prevention
For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer. Now, a landmark phase 3 clinical trial of a personalized melanoma vaccine shows that this approa
<p>For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer. Now, a landmark phase 3 clinical trial of a personalized melanoma vaccine shows that this approa</p>